169 related articles for article (PubMed ID: 22687567)
1. The effect of race and gender on the surgical management of the small renal mass.
Kates M; Whalen MJ; Badalato GM; McKiernan JM
Urol Oncol; 2013 Nov; 31(8):1794-9. PubMed ID: 22687567
[TBL] [Abstract][Full Text] [Related]
2. Race and sex disparities in the treatment of older patients with T1a renal cell carcinoma: a comorbidity-controlled competing-risks model.
Patel HD; Kates M; Pierorazio PM; Allaf ME
Urol Oncol; 2014 Jul; 32(5):576-83. PubMed ID: 24629500
[TBL] [Abstract][Full Text] [Related]
3. Toward greater adoption of minimally invasive and nephron-sparing surgical techniques for renal cell cancer in the United States.
Banegas MP; Harlan LC; Mann B; Yabroff KR
Urol Oncol; 2016 Oct; 34(10):433.e9-433.e17. PubMed ID: 27321355
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous Ablation Versus Partial and Radical Nephrectomy for T1a Renal Cancer: A Population-Based Analysis.
Talenfeld AD; Gennarelli RL; Elkin EB; Atoria CL; Durack JC; Huang WC; Kwan SW
Ann Intern Med; 2018 Jul; 169(2):69-77. PubMed ID: 29946703
[TBL] [Abstract][Full Text] [Related]
5. A non-cancer-related survival benefit is associated with partial nephrectomy.
Sun M; Trinh QD; Bianchi M; Hansen J; Hanna N; Abdollah F; Shariat SF; Briganti A; Montorsi F; Perrotte P; Karakiewicz PI
Eur Urol; 2012 Apr; 61(4):725-31. PubMed ID: 22172373
[TBL] [Abstract][Full Text] [Related]
6. Association of race and margin status among patients undergoing robotic partial nephrectomy for T1 renal cell carcinoma: Results from a population-based cohort.
Chen VS; Abouassaly R; Gonzalez CM; Kutikov A; Smaldone MC; Meropol NJ; Psutka SP; Williams SB; O'Malley R; Sedlacek HM; Kim SP
Urol Oncol; 2017 Nov; 35(11):662.e17-662.e21. PubMed ID: 28781110
[TBL] [Abstract][Full Text] [Related]
7. Compared with radical nephrectomy, nephron-sparing surgery offers a long-term survival advantage in patients between the ages of 20 and 44 years with renal cell carcinomas (≤4 cm): an analysis of the SEER database.
Daugherty M; Bratslavsky G
Urol Oncol; 2014 Jul; 32(5):549-54. PubMed ID: 24495447
[TBL] [Abstract][Full Text] [Related]
8. Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach.
Badalato GM; Kates M; Wisnivesky JP; Choudhury AR; McKiernan JM
BJU Int; 2012 May; 109(10):1457-62. PubMed ID: 21933334
[TBL] [Abstract][Full Text] [Related]
9. A population-based comparison of cancer-control rates between radical and partial nephrectomy for T1A renal cell carcinoma.
Crépel M; Jeldres C; Sun M; Lughezzani G; Isbarn H; Alasker A; Capitanio U; Shariat SF; Arjane P; Widmer H; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
Urology; 2010 Oct; 76(4):883-8. PubMed ID: 20932408
[TBL] [Abstract][Full Text] [Related]
10. A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma.
Bianchi M; Gandaglia G; Trinh QD; Hansen J; Becker A; Abdollah F; Tian Z; Lughezzani G; Roghmann F; Briganti A; Montorsi F; Karakiewicz PI; Sun M
Urol Oncol; 2014 Jan; 32(1):46.e1-7. PubMed ID: 24054864
[TBL] [Abstract][Full Text] [Related]
11. Race/Ethnicity Determines Life Expectancy in Surgically Treated T1aN0M0 Renal Cell Carcinoma Patients.
Würnschimmel C; Collà Ruvolo C; Nocera L; Wenzel M; Tian Z; Saad F; Briganti A; Shariat SF; Mirone V; Chun FKH; Tilki D; Graefen M; Karakiewicz PI
Eur Urol Focus; 2022 Jan; 8(1):191-199. PubMed ID: 33610487
[TBL] [Abstract][Full Text] [Related]
12. Effect of African-American race on cancer specific mortality differs according to clear cell vs. non-clear cell histologic subtype in metastatic renal cell carcinoma.
Marchioni M; Harmouch SS; Nazzani S; Bandini M; Preisser F; Tian Z; Kapoor A; Cindolo L; Briganti A; Shariat SF; Schips L; Karakiewicz PI
Cancer Epidemiol; 2018 Jun; 54():112-118. PubMed ID: 29715680
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Partial Versus Radical Nephrectomy Effect on Other-cause Mortality, Cancer-specific Mortality, and 30-day Mortality in Patients Older Than 75 Years.
Marchioni M; Preisser F; Bandini M; Nazzani S; Tian Z; Kapoor A; Cindolo L; Abdollah F; Tilki D; Briganti A; Montorsi F; Shariat SF; Schips L; Karakiewicz PI
Eur Urol Focus; 2019 May; 5(3):467-473. PubMed ID: 29398456
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological characteristics and outcomes of surgically excised renal masses in African Americans.
Qi P; Tsivian M; Abern MR; Passoni NM; McGinley KF; Polascik TJ
Urol Oncol; 2014 Jul; 32(5):555-60. PubMed ID: 24495445
[TBL] [Abstract][Full Text] [Related]
15. Comparative Effectiveness of Thermal Ablation, Surgical Resection, and Active Surveillance for T1a Renal Cell Carcinoma: A Surveillance, Epidemiology, and End Results (SEER)-Medicare-linked Population Study.
Xing M; Kokabi N; Zhang D; Ludwig JM; Kim HS
Radiology; 2018 Jul; 288(1):81-90. PubMed ID: 29737950
[TBL] [Abstract][Full Text] [Related]
16. Racial Disparities in Histology and Short-Term Renal Functional Outcomes Following Robotic Nephron-Sparing Surgery.
Wang JC; Lai WR; Traore EJ; Liu J; Sholl AB; Mandava SH; Maddox MM; Mitchell GC; Viriyasiripong S; Silberstein JL; Kittles R; Lee BR
Clin Genitourin Cancer; 2017 Apr; 15(2):203-206. PubMed ID: 27554583
[TBL] [Abstract][Full Text] [Related]
17. Evolving practice patterns for the management of small renal masses in the USA.
Yang G; Villalta JD; Meng MV; Whitson JM
BJU Int; 2012 Oct; 110(8):1156-61. PubMed ID: 22372984
[TBL] [Abstract][Full Text] [Related]
18. Race and postoperative complications following urologic cancer surgery: An ACS-NSQIP analysis.
Parker DC; Handorf E; Smaldone MC; Uzzo RG; Pitt H; Reese AC
Urol Oncol; 2017 Dec; 35(12):670.e1-670.e6. PubMed ID: 28867431
[TBL] [Abstract][Full Text] [Related]
19. Comparison of survival for partial vs. radical nephrectomy in young patients with T1a renal cell carcinoma treated at commission on cancer-accredited facilities and influence of comorbidities on treatment choice.
Wang DC; Plante K; Stewart T; Wang D; Formica M; Daugherty M; Bratslavsky G
Urol Oncol; 2017 Nov; 35(11):660.e9-660.e15. PubMed ID: 28736248
[TBL] [Abstract][Full Text] [Related]
20. Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors.
Kaushik D; Kim SP; Childs MA; Lohse CM; Costello BA; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
Eur Urol; 2013 Oct; 64(4):600-6. PubMed ID: 23280319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
